Immunoliposomes that optimize internationalization into target cells
First Claim
1. An immunoliposome that is internalized into a cell bearing a growth factor receptor on its cell surface, said immunoliposome comprising:
- a hydrophilic polymer derivatized lipid;
a recombinantly produced antibody fragment specifically binding to the receptor on the cell surface said fragment attached to the hydrophilic polymer of the derivatized lipid; and
, an amphipathic vesicle-forming lipid, said vesicle-forming lipid forming a liposome; and
, wherein when said immunoliposome is contacted with said cell bearing a growth factor receptor on its cell surface, said immunoliposome is internalized into the cell and where the growth factor receptor is selected from the group consisting of HER 1, HER2, HER3 and HER4.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides for immunoliposomes that optimizes internalization of a drug into target cells bearing a characteristic cell surface marker. The immunoliposomes comprise an Fab′ domain of an antibody that specifically binds the characteristic marker, an amphipathic vesicle-forming lipid, and a polyethylene glycol derivatized lipid. The invention also provides for growth-inhibiting immunoliposomes that lack growth-inhibiting therapeutic agents and yet are capable of inhibiting the growth and proliferation of target cells.
-
Citations
5 Claims
-
1. An immunoliposome that is internalized into a cell bearing a growth factor receptor on its cell surface, said immunoliposome comprising:
-
a hydrophilic polymer derivatized lipid;
a recombinantly produced antibody fragment specifically binding to the receptor on the cell surface said fragment attached to the hydrophilic polymer of the derivatized lipid; and
,an amphipathic vesicle-forming lipid, said vesicle-forming lipid forming a liposome; and
, wherein when said immunoliposome is contacted with said cell bearing a growth factor receptor on its cell surface, said immunoliposome is internalized into the cell and where the growth factor receptor is selected from the group consisting of HER 1, HER2, HER3 and HER4. - View Dependent Claims (2, 3, 4, 5)
-
Specification